6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returns of 14.08% in the quarter slightly lagged the 14.55% return for the Russell Midcap Growth Index. The fund declined 27.14% for […]
https://www.investing.com/news/stock-market-news/citi-maintains-buy-rating-on-dexcom-with-148-target-93CH-3352064
What''s Driving DexCom Inc''s Surprising 14% Stock Rally?
S&P 500 stocks DexCom, Blackstone and Royal Caribbean lead five stocks around buy points after Fed chief Jerome Powell helped buoy markets.
DexCom shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That’s according to Emergen Research. By 2034, it could hit $888.1 billion , says Prophecy Market Insights. All creating big opportunities for telemedicine stocks. First made popular during the pandemic, it’s become a much-needed fixture for a lot of patients who just don’t want to drive to the doctor or sit in the waiting room. Unless there’s a medical emergency that requires a doctor visit, patients can get prescriptions, treatment recommendations or even have their vitals checked with connected medical devices. Telehealth platforms are even great for visits with mental health professionals. For example, according to mHealth Intelligence , “Digital mental health visits are also among trends in telemedicine as they rank highest among the specialties in 2023. According to statistics, by the third quarter of 2023, 37% of mental health visits took place virtually, followed by infectious disease, obstetrics and transplant.” While I personally like to visit my doctor for a more thorough examination, millions of people are opting for telehealth care.
Dexcom is Wednesday''s IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor.
No summary available.